반응식
[Cl:1][C:2]1[CH:3]=[CH:4][C:5]([C:23]#[N:24])=[C:6]([C:8]2[C:13]([O:14][CH3:15])=[CH:12][N:11]([CH:16]([CH2:20][CH3:21])[C:17](O)=[O:18])[C:10](=[O:22])[CH:9]=2)[CH:7]=1.[NH2:25][C:26]1[CH:35]=[CH:34][C:29]2[NH:30][C:31](=[O:33])[NH:32][C:28]=2[CH:27]=1>>[Cl:1][C:2]1[CH:3]=[CH:4][C:5]([C:23]#[N:24])=[C:6]([C:8]2[C:13]([O:14][CH3:15])=[CH:12][N:11]([CH:16]([CH2:20][CH3:21])[C:17]([NH:25][C:26]3[CH:35]=[CH:34][C:29]4[NH:30][C:31](=[O:33])[NH:32][C:28]=4[CH:27]=3)=[O:18])[C:10](=[O:22])[CH:9]=2)[CH:7]=1참가 물질
3
실험 절차
71 mg (0.20 mmol) of 2-[4-(5-chloro-2-cyanophenyl)-5-methoxy-2-oxopyridin-1(2H)-yl]butanoic acid (racemate) and 33 mg (0.22 mmol, 1.1 eq.) of 5-amino-1,3-dihydro-2H-benzimidazol-2-one were reacted according to General Method 1. Yield: 74 mg (76% of theory)
출처 및 근거
- ORD 기록
- ord-e5fc2c91e0194067bcfd438f882ed853
- 출처 데이터셋
- uspto-grants-2016_09
- 특허 번호
- US09434690B2
연결된 노트
불러오는 중…